GeneDx Holdings Corp. (WGS) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.69x

GeneDx Holdings Corp. (WGS) has a Cash Flow Reinvestment Rate of 0.69x as of September 2025, reinvesting $10.86 Million (capex $6.17 Million plus investments $-4.69 Million) from operating cash flow of $15.77 Million. Explore GeneDx Holdings Corp. (WGS) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.69x
(Capex + Investments) / Operating CF

Total Reinvested

$10.86 Million
Capex + Investments

Operating Cash Flow

$15.77 Million
USD

Capital Expenditures

$6.17 Million
USD

GeneDx Holdings Corp. Cash Flow Reinvestment Rate (2025–2025)

Historical reinvestment intensity for GeneDx Holdings Corp. across 1 annual periods. Also explore WGS total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for GeneDx Holdings Corp. (2025–2025)

Year-by-year capital reinvestment analysis for GeneDx Holdings Corp.. For live market cap and broader valuation context, see WGS company net worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.86x $28.66 Million $33.28 Million $19.02 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow